AT&T, U.S. Bancorp And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones dropping over 300 points on Wednesday. Here are some big stocks recording gains in today’s session.
A Preview Of Monro’s Earnings
Monro (NASDAQ:MNRO) is set to give its latest quarterly earnings report on Wednesday, 2023-01-25. Here’s what investors need…
Monro Shares Drop On Q2 Earnings Miss
Monro Inc (NASDAQ:MNRO) reported a second-quarter FY23 sales decline of 5.1% year-on-year to $329.82 million, missing the consensus of $345.58…
Monro Q2 EPS $0.43 Misses $0.45 Estimate, Sales $329.82M Miss $345.58M Estimate
Monro (NASDAQ:MNRO) reported quarterly earnings of $0.43 per share which missed the analyst consensus estimate of $0.45 by 4.44 percent. This is a 30.65 percent decrease over earnings of $0.62 per share from the same
Monro Q1 EPS $0.42 Beats $0.32 Estimate, Sales $349.54M Beat $343.51M Estimate
Monro (NASDAQ:MNRO) reported quarterly earnings of $0.42 per share which beat the analyst consensus estimate of $0.32 by 31.25 percent. This is a 23.64 percent decrease over earnings of $0.55 per share from the same
Earnings Scheduled For July 27, 2022
Companies Reporting Before The Bell
• Equinor (NYSE:EQNR) is projected to report earnings for its second quarter.
Monro Completes Sale Of Tires Now Assets To American Tire Distributors
Monro Inc (NASDAQ:MNRO) has completed the previously-announced sale of its wholesale tire and distribution assets to American Tire Distributors (ATD). The…
Why Monro Shares Are Sliding Today
Monro Inc (NASDAQ:MNRO) reported fourth-quarter FY22 sales growth of 7.4% year-on-year, to $328 million, beating the consensus of $324.66 million. The…
38 Stocks Moving In Thursday’s Mid-Day Session
Gainers
NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia.